RARITAN, N.J., July 26, 2011 /PRNewswire/ -- Ortho Clinical Diagnostics (OCD) today announced availability of seven manufacturer-validated applications for the VITROS® 5,1 FS and 4600 Chemistry Systems.

RARITAN, N.J., July 22, 2011 /PRNewswire/ -- Ortho Clinical Diagnostics (OCD) today announced the launch of the VITROS® 4600 Chemistry System, a state-of-the-art analyzer that delivers high-quality, reliable test results for mid- to high-volume laboratories using the same core technologies that drive reliability and efficiency throughout OCD's portfolio of products.

RARITAN, N.J., Nov. 1, 2010 /PRNewswire/ -- Ortho Clinical Diagnostics today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the VITROS® intact Parathyroid Hormone (iPTH) Assay.

DALLAS, June 7, 2010 /PRNewswire/ -- ReportsandReports Announces it Will Carry the Clinical Diagnostics in India: Market Analyses and Participant Directory Market ( http://www.reportsandreports.com/Report/25249/) Research Report in its Store. Browse the complete Report on: http://www.reportsandreports.com/market-reports/clinical-diagnostics-in-india -market-analyses-and-participant-di/ (Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field.

NEW YORK, Dec.